Grifols in the news
Healthcare solutions and services
Tamtam found 20 recent articles about Grifols.
- The Grifols paid plasma clinic has reopened in Hamilton. Here’s what’s changed
Grifols' Hamilton paid plasma clinic has reopened with reduced appointments under increased Health Canada oversight, following a temporary closure due to systemic deficiencies and donor deaths in Winnipeg.
- El Ibex 35 cae a mínimos de dos semanas lastrado por Solaria Energía y Grifols
Ibex 35 drops to a two-week low, driven by declines in Solaria Energía and Grifols, amid anticipation of an ECB interest rate hike.
- Grifols falls 3.07% in Thursday's session
Grifols stock fell 3.07% to 11.06 euros in Thursday's trading session.
- Grifols se desploma un 3,71 % en bolsa: el soporte clave que preocupa al mercado
Grifols' stock dropped 3.71% to 11.045 euros due to short-term selling pressure and lack of catalysts, while the market watches key support and resistance levels.
- Grifols presenta nuevos datos de un estudio realizado en pacientes con alzheimer
Grifols unveiled new study data concerning Alzheimer's patients.
- Daniel Yu (Gotham) desvela al juez dónde vive para eludir el pleito de Grifols
Gotham City Research founder Daniel Yu claims Hong Kong residency to avoid a New York lawsuit by Grifols, which accuses Gotham of market manipulation.
- Las acciones de Grifols se consolidan cerca de la resistencia de €11,63 mientras las señales técnicas siguen siendo mixtas
Grifols shares consolidate near •11.63 resistance with mixed technical signals, while Morgan Stanley significantly increased its stake in the company.
- Grifols SA (OZTA.HM) Analyst insights, Price targets and Recommendations
Grifols SA declared a cash dividend of EUR 0.15 with an ex-date of December 2, 2026.
- Alemania golpeará las ventas de Almirall, Rovi y PharmaMar mientras blinda a Grifols
Germany's new pharmaceutical discount reform will negatively impact sales for Almirall, Rovi, and PharmaMar, while Grifols will be protected.
- 'La Cartera' eleva la protección sobre Amadeus y Grifols
ElEconomista.es's 'La Cartera Estratégica' has increased profit protection for Amadeus and Grifols following their positive stock performance, raising stop-loss levels to secure higher gains for both companies.
- Grifols stock advances as US biopharma IPO plan takes shape
Grifols plans an IPO of its US biopharma business to reduce debt, following strong third-quarter growth in its Biopharma division.
- Grifols (NASDAQ:GRFS) Upgraded at Wall Street Zen
Grifols received a 'buy' upgrade from Wall Street Zen, contrasting with other analysts' 'neutral' to 'strong sell' ratings, while its stock traded down.
- Grifols, S.A. (GRFS) Stock Forecasts
Grifols collects plasma, manufactures, and sells plasma-derived products globally, expanding its portfolio with the 2011 Talecris acquisition.
- Grifols stock weighs US Biopharma IPO as leverage falls
Grifols is considering an IPO for its US Biopharma unit while actively reducing its debt through strong operating cash flow and achieving positive third-quarter financial results.
- Grifols stock gains IPO angle as US business stake sale advances
Grifols plans to sell a minority stake in its US business through an IPO to reduce debt and improve financial flexibility.
- Grifols stock: Board backs US business IPO to reduce debt
Grifols plans to list a minority stake of its US business on the stock market to help pay down its debt.
- El Ibex 35 sube tímidamente y aguanta los 20.000 puntos, liderado por ACS y Grifols
The IBEX 35 slightly increased, led by ACS and Grifols, while Telefónica shares fell after its quarterly results.
- Grifols, S.A. (GIKLY) Seasonal returns chart
Grifols announced a cash dividend of $0.084 with an ex-date of December 3, 2026.
- Potencial de más del 100% para esta acción del Ibex 35 en pleno rebote
Grifols stock has a potential upside of over 100% according to analysts, while Morgan Stanley has increased its stake in the company.
- Grifols stock rises 1.59% from prior report as Q3 focus holds
Grifols' stock increased by 1.59%, driven by strong Q3 cash generation, reduced leverage, and anticipation of positive results from its SPARTA study.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Grifols?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies